RBI Call/ams 24-25/ AT0000A3CK30 /
29.05.2024 9:15:00 | Изменение0.000 | Бид17:29:03 | Предложение17:29:03 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
0.540EUR | 0.00% | - Величина цены спроса: - |
- Величина цены предложения: - |
- | 1.20 EUR | 19.09.2025 | Call |
GlobeNewswire
8:14
STMicroelectronics to build the world’s first fully integrated silicon carbide facility in Italy
GlobeNewswire
8:00
Nyxoah Announces Closing of Offering and Partial Exercise of Option to Purchase Additional Shares
GlobeNewswire
7:30
Baosheng Media Group Holdings Limited Announces Filing of Current Report on Form 6-K with the SEC re...
GlobeNewswire
7:05
Dupixent® (dupilumab) Recommended for EU Approval by the CHMP to Treat Patients with COPD
GlobeNewswire
7:05
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD
GlobeNewswire
7:00
Update on FDA Priority Review of Dupixent® (dupilumab) for the Treatment of COPD Patients with Type ...
GlobeNewswire
7:00
Press Release: Update on FDA priority review of Dupixent for the treatment of COPD patients with typ...
GlobeNewswire
7:00
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
6:08
Sen. John Cornyn delivers remarks at Driscoll Children's Hospital Rio Grande Valley
GlobeNewswire
5:00
Flash News: OKX to List Ultiverse's Token on its Spot Market, Expanding Trading Options
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница